Bionow | News

UK Supplier expands to provide Chemically Defined & Serum-Free Cell Media Soluti...

Nov 15th 2022

BioPharma Dynamics, a leading life sciences solution provider, proudly expand their extensive portfolio for the Cell & Gene Therapy market to offer a range of chemically defined T-Cell Media...

New study into cancer cells to help improve chemotherapy effectiveness

Mar 2nd 2022

A new Liverpool led study, published in Gut, has identified how immune cells in the body can promote the regrowth of cancer cells after chemotherapy withdrawal. These findings will help impr...

UK Innovators Target Nanoparticles at Inoperable Cancers

Dec 21st 2020

Active Needle Technology, Xerion Healthcare and Medicines Discovery Catapult win funding to begin ground-breaking project

CELLINK and Atelerix team up to enable the shipping at room temperature of fragi...

Dec 4th 2020

CELLINK and Atelerix announced today a partnership to bring to market Atelerix’s portfolio of innovative hydrogel biological encapsulation products, which preserve fragile biological sam...

Liability on the Frontline - Part 1: Emerging risks in Covid-19 clinical trials

Oct 14th 2020

With the scientific community throwing everything it has at Covid-19, best practice is slipping in clinical trials. What trade-offs are being made and who is liable?

IDEXX report on the genetic variability of the MC-38 cell line

Aug 19th 2020

IDEXX Bioanalytics report on the application of their 19 loci Short Tandem Repeat (STR) assay to screen 3 different cell banks of MC-38 submitted by a single company. Their analysis shows t...

N4 Pharma Covid-19 Project Update

Apr 16th 2020

N4 Pharma Plc , the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide an update on the timing and work t...

Gender medicine – deriving novelty from treating women?

Aug 29th 2019

When you hear the term “gender medicine”, what comes to mind? For many people, the term is associated with reproductive health issues, such as pregnancy, genitourinary medicine, or endoc...

Atelerix Consortium Awarded £267,000 Innovate UK Grant for collaboration with t...

Aug 21st 2019

Cambridge and Newcastle, UK, 21st August 2019: Atelerix, pioneers in the storage and transport of cells at room temperature, today announces that it has been awarded a grant of £267,000 fro...

Atelerix completes successful follow-on funding round

May 9th 2019

Atelerix, creators of an innovative cell encapsulation technology, today announces it has closed a second round of funding of £700,000 to accelerate development of its cell transport produc...

Researchers capture prostate cancer cells changing the cells around them for the...

Apr 26th 2019

Prostate cancer cells change the behaviour of other cells around them, including normal cells, by ‘spitting out’ a protein from their nucleus, new research has found, and the process has...

Pioneering Research revealed to help people fight germs and combat disease

Oct 11th 2018

Researchers from the University of Hull have presented some of the latest research in fighting germs and combatting disease at the British Science Festival.

News